Product Information
METHYLPHENIDATE 5 MG CHEW TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $2.0092 per EA under NDC 64980022201. Its NADAC has been published 317 times since Mar 18, 2020.
FDA first approved this application on Nov 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980022201
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205756FDA Approved
11/7/2016
TE Code
AB
On Market Since
12/18/2018
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG CHEW TAB has been published 317 times since Mar 18, 2020, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0092 per EA |
|---|---|
| All-time high | $3.3966 (Apr 13, 2022) |
| All-time low | $1.7116 (Nov 20, 2024) |
| 52-week high | $2.0092 |
| 52-week low | $1.8202 |
| Median price | $2.2173 |
| Average price | $2.3719 |
| Largest weekly change | +43.0% (Feb 17, 2021) |
| Weeks tracked | 317 |
| Tracking since | Mar 18, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG CHEW TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG CHEW TAB, manufactured by Rising Pharma Holdings Inc., is $2.0092 per EA (NDC 64980022201), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 5 MG CHEW TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG CHEW TAB has declined 35.3%. It has been tracked across 317 weekly CMS publications since Mar 18, 2020.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG CHEW TAB?
Since Mar 18, 2020, the NADAC for METHYLPHENIDATE 5 MG CHEW TAB has ranged from a low of $1.7116 (Nov 20, 2024) to a high of $3.3966 (Apr 13, 2022), with a median of $2.2173 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG CHEW TAB?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 5 MG TABLET, is $0.0858 per EA — about 96% below METHYLPHENIDATE 5 MG CHEW TAB.
Who manufactures METHYLPHENIDATE 5 MG CHEW TAB?
METHYLPHENIDATE 5 MG CHEW TAB (NDC 64980022201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.